News
1don MSN
Vaccinating young children against Covid-19 may be more challenging this respiratory virus season
Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...
mlive on MSN12h
‘Potential exposure’ at Portage Pfizer plant sends people to hospital, MIOSHA investigating
Several workers reported symptoms of being exposed to a substance and some were taken to the hospital. The state is ...
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
Covid-19 levels are on the rise in the US, with transmission increasing in at least 45 states. Yet people who want to get vaccinated this fall may face a growing set of obstacles. Last week, the CDC ...
6don MSN
Are mRNA Vaccines Safe — and Should You Still Get a COVID Shot? Doctors on the Pros and Cons
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...
American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain's GSK and Germany's CureVac US$740 ...
Pfizer delivered a strong Q2 earnings beat, raising FY2025 guidance and demonstrating effective cost-cutting. Learn why PFE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback